[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [RiskMitigation](https://github.com/mm80843/T3.5/tree/main/docs/RiskMitigation/index.md) >> Individual ID:PBN__Mitigation_850 

# __Tissue culture infectious dose at the 50% endpoint (TCID50) technique__

## Property: has_MitigationPrinciple

Determines viral titers in the test virus suspension

## Property: has_MitigationSource

* [A Continuously Active Antimicrobial Coating effective against Human Coronavirus 229E](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_246.md)

## This Mitigation is enabled by the following technologies

* [tcid50 technique](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3493.md)

## Risks possibly mitigated by this Mitigation


